Diabetes therapy
Researchers at the Indian Institute of Technology Guwahati have made a significant advancement in the production of recombinant human insulin using novel promoters in Pseudomonas fluorescens. The study aimed to develop an IPTG-free expression system, which is crucial for large-scale production of insulin. The research demonstrated the use of constitutive
Diabetes therapy
Researchers at the University of Chicago have shed light on the complex mechanisms underlying insulin degradation, a process crucial for preventing toxic amyloid fibril formation. By examining the structure and dynamics of insulin degrading enzyme (IDE), the research team has identified key residues and interfaces that facilitate the enzyme'
Amylases
Researchers have made a significant discovery in understanding the relationship between salivary amylase activity and glucose homeostasis, insulin secretion, and appetite regulation. According to a review published in the Journal of Nutritional Biochemistry, salivary amylase, a key enzyme in carbohydrate digestion, has emerged as a potential regulator of metabolic processes.
Diabetes therapy
Research conducted by Shin Kong Wu Ho-Su Memorial Hospital has found that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a lower risk of lung cancer, pneumonia, and pulmonary fibrosis in patients with type 2 diabetes. The study analyzed a large cohort of patients with type 2 diabetes and
Diabetes therapy
Researchers from Guizhou Medical University have made new findings in the field of peptide proteins - proinsulin, providing insights into potential treatment options for diabetes. The study, funded by the Guizhou Provincial Basic Research Program and the Innovation and Entrepreneurship Training Program for College Students in Guizhou Province, focused on
Diabetes therapy
Research conducted by Shin Kong Wu Ho-Su Memorial Hospital has found that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a lower risk of lung cancer, pneumonia, and pulmonary fibrosis in patients with type 2 diabetes. The study analyzed a large cohort of patients with type 2 diabetes and
Diabetes therapy
Researchers at the University of Chicago have shed light on the complex mechanisms underlying insulin degradation, a process crucial for preventing toxic amyloid fibril formation. By examining the structure and dynamics of insulin degrading enzyme (IDE), the research team has identified key residues and interfaces that facilitate the enzyme'
Diabetes therapy
Researchers at the University of Chicago have shed light on the complex mechanisms underlying insulin degradation, a process crucial for preventing toxic amyloid fibril formation. By examining the structure and dynamics of insulin degrading enzyme (IDE), the research team has identified key residues and interfaces that facilitate the enzyme'
Diabetes therapy
Research conducted by Shin Kong Wu Ho-Su Memorial Hospital has found that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a lower risk of lung cancer, pneumonia, and pulmonary fibrosis in patients with type 2 diabetes. The study analyzed a large cohort of patients with type 2 diabetes and
Diabetes therapy
Researchers from Guizhou Medical University have made new findings in the field of peptide proteins - proinsulin, providing insights into potential treatment options for diabetes. The study, funded by the Guizhou Provincial Basic Research Program and the Innovation and Entrepreneurship Training Program for College Students in Guizhou Province, focused on
Amylases
Researchers have made a significant discovery in understanding the relationship between salivary amylase activity and glucose homeostasis, insulin secretion, and appetite regulation. According to a review published in the Journal of Nutritional Biochemistry, salivary amylase, a key enzyme in carbohydrate digestion, has emerged as a potential regulator of metabolic processes.
Diabetes therapy
Researchers have made a significant discovery in understanding the relationship between salivary amylase activity and glucose homeostasis, insulin secretion, and appetite regulation. According to a review published in the Journal of Nutritional Biochemistry, salivary amylase, a key enzyme in carbohydrate digestion, has emerged as a potential regulator of metabolic processes.
